New study reveals Oxford coronavirus vaccine produces strong immune response
A team of scientists at Oxford Vaccine Group (Department of Paediatrics) and Oxford University’s Jenner Institute has taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus.
Read moreTyphoid vaccine project wins Vice-Chancellor award
Congratulations to Professor Andrew Pollard who is the Winner of the Policy Engagement category in the Vice-Chancellor Innovation Awards 2020 for his work on Global policy on typhoid vaccines through research at Oxford!
Read moreEbola vaccine approved for use by the European Commission
The European Commission has granted Marketing Authorisation to Janssen for a new Ebola vaccine, developed in partnership with the University of Oxford.
Read moreCoronavirus: is it safe for children to return to school?
Stéphane Paulus and Else Bijker explore the topic in their article for The Conversation.
Read morePaediatrics professor honoured by the Academy of Medical Sciences
The Academy of Medical Sciences, the independent body in the UK representing the diversity of medical science, has announced the election of fifty new Fellows, including Professor Matthew Wood from the Department of Paediatrics.
Read moreHIV study explains immunological differences between sexes
How can researching a cohort of infants from KwaZulu-Natal in South Africa help explain differing HIV susceptibility of males and females? Professor Philip Goulder, head of the HIV Research Group, discusses the Baby Cure study.
Read moreResearch
Research in our Department focuses on a wide variety of aspect of children's health. We study the neuroscience of pain in infants, HIV, immunology, haematology, gastroenterology, neuromuscular diseases and vaccinology.
Teaching
Get involved
What's new
Typhoid vaccine project wins Vice-Chancellor award
27 July 2020
Congratulations to Professor Andrew Pollard who is the Winner of the Policy Engagement category in the Vice-Chancellor Innovation Awards 2020 for his work on Global policy on typhoid vaccines through research at Oxford!
New study reveals Oxford coronavirus vaccine produces strong immune response
20 July 2020
A team of scientists at Oxford Vaccine Group (Department of Paediatrics) and Oxford University’s Jenner Institute has taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus.
Ebola vaccine approved for use by the European Commission
2 July 2020
The European Commission has granted Marketing Authorisation to Janssen for a new Ebola vaccine, developed in partnership with the University of Oxford.
The Duke of Cambridge visits Oxford Vaccine Centre
26 June 2020
The Duke of Cambridge visits the University of Oxford’s Oxford Vaccine Centre, to learn more about their work to establish a viable vaccine against COVID-19.
Latest publications
-
Integrating large-scale neuroimaging research datasets: harmonisation of white matter hyperintensity measurements across Whitehall and UK Biobank datasets
Journal article
Bordin V. et al, (2020), bioRxiv
-
The Surveillance for Enteric Fever in Asia Project (SEAP), Severe Typhoid Fever Surveillance in Africa (SETA), Surveillance of Enteric Fever in India (SEFI), and Strategic Typhoid Alliance Across Africa and Asia (STRATAA) Population-based Enteric Fever Studies: A Review of Methodological Similarities and Differences.
Journal article
Carey ME. et al, (2020), Clin Infect Dis, 71, S102 - S110
-
Early Insights From Clinical Trials of Typhoid Conjugate Vaccine
Journal article
Neuzil KM. et al, (2020), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71, S155 - S159
-
Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants.
Journal article
Lin G-L. et al, (2020), J Infect Dis
-
The impact of Brexit on the UK pharmaceutical supply chain: a scoping review protocol
Journal article
Milne-Ives M. et al, (2020), JMIR Research Protocols
-
Mobile fitness and weight management apps: an evaluation protocol
Journal article
Milne-Ives M. et al, (2020), JMIR Research Protocols
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Journal article
Folegatti PM. et al, (2020), Lancet
Upcoming events
Online Introduction to Immunisation Training - 7 October 2020
Wednesday, 07 October 2020, 9.30am to 2.30pm
This training is for general practice nurses and other health professionals who are new to the role of administering and promoting and / or advising about vaccines.
Online Introduction to Immunisation Training - 3 November 2020
Tuesday, 03 November 2020, 9.30am to 2.30pm
This training is for general practice nurses and other health professionals who are new to the role of administering and promoting and / or advising about vaccines.
Featured
Oxford-Harrington Rare Diseases Centre
ORDI helps to facilitate relationships between Oxford’s researchers, clinicians, and the wider rare disease community.
Vaccine Knowledge Project
The Vaccine Knowledge Project provides independent. authoritative and accessible scientific information about vaccination.
MDUK Oxford Neuromuscular Centre
We drive the development of novel experimental therapies and increase national clinical trial capacity in neuromuscular diseases.
Paediatric Neuroimaging
The Paediatric Neuroimaging Group aims to improve understanding of human brain development, with a particular focus on improving the treatment of infant pain.
For access to staff pages and student pages, please remember to log into the site with your Oxford Single Sign on at the top right hand side of the page.
If you're not immune to measles you can catch it just by going into a room up to 2 hours after an infected person has left it!
